Clinical trial
A Comparison of Injected Insulin Replacement Therapy With A Novel Transdermally Delivered Human Insulin Product
NCT03544996 is registered in ClinicalTrials.gov with Transdermal Delivery Solutions Corp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Injected Insulin Replacement Therapy With A Novel Transdermally Delivered Human Insulin Product
- Lead sponsor
- Transdermal Delivery Solutions Corp
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 9, 2017
- Completion date
- February 4, 2018
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypoinsulinemia